Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Person

Matt Gentry

Tracked across 1 events · 7 articles · First seen Jun 09, 2026 · Last active Jun 11, 2026

Sentiment
10
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 10
Tech
New research from the University of Florida has found a concerning association between taking Glucosamine, a popular over-the-counter supplement for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer s…
Impact: Matt Gentry, Ph.D., chair of UF's Department of Biochemistry and Molecular Biology and a study co-author, provided insights into the biological context of Glucosamine's impact and the overactive sugar-tagging system in Alzheimer's.
Jun 09, 2026 · 7 articles
NEWSDESK
Track Matt Gentry live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.